(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CELULARITY IMPACT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CELULARITY IMPACT

ST13

US500000097265928

Class

40, 42

Filing

97265928

Registration

6782541

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

07/05/2022

Trademark type

Word

Nice classes

40, 42

Filing date

02/14/2022

Registration date

07/05/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/05/2022

Last transaction

07/05/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

03/29/2019

First use in commerce

03/29/2019

Drawing code

4

Owner type

03

Owner location

Florham Park, NJ, US

Examiner

CHOI, REBECCA

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Celularity Inc.

Representatives

CAMILLE M. MILLER COZEN O'CONNOR

Technical classification

Nice Classes

Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Manufacturing services of biopharmaceuticals and gene and cell therapy productsgenetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banksplasmidspurified mitochondriacell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting

Class 42

Researchdevelopment and testing services in the fields of genomicsbiotechnology and pharmaceuticalscollectiontestingprocessingpreservationstorage and retrieval of cells and biological tissuebloodstem cellsumbilical cordsumbilical cord bloodplacental tissue; laboratory research services in the field of genomicsbiotechnology and pharmaceuticals consisting of collectiontestingprocessingpreservationstorage and retrieval of bioengineered cellshuman allograft tissue made from human umbilical cords and human placentashuman amniotic membrane and human chorionic membranehuman collagen and extracellular matrix compositions; providing a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessibleimmune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; scientific and technological servicesscientific researchanalysistesting in the field of genomicsbiotechnologypharmaceuticals; medical research to find methods to restore the structure and function of damaged or diseased tissues and organsincluding wound carereconstructive medicinewhole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line informationnews and commentary in the field of medical research relating to the foregoing; researchdevelopment and testing services for others in the fields of genomicsbiotechnology and pharmaceuticals

Publications

History of USPTO decisions and trademark events.

14 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/05/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/19/2022

PUBO

PUBLISHED FOR OPPOSITION

04/19/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/30/2022

ALIE

ASSIGNED TO LIE

03/15/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/11/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

03/11/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/11/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

03/11/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/11/2022

DOCK

ASSIGNED TO EXAMINER

03/01/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/18/2022

NWAP

NEW APPLICATION ENTERED

02/17/2022

Continuous trademark protection

Get notified about every new filing that threatens CELULARITY IMPACT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.